Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |